NF-κB is important in regulating cellular responses because it belongs to the category of "rapid-acting" primary transcription factors, i.e., transcription factors that are present in cells in an inactive state and do not require new protein synthesis in order to become activated (other members of this family include transcription factors such as c-Jun, STATs, and nuclear hormone receptors). This allows NF-κB to be a first responder to harmful cellular stimuli. Known inducers of NF-κB activity are highly variable and include reactive oxygen species (ROS), tumor necrosis factor alpha (TNFα), interleukin 1-beta (IL-1β), bacterial lipopolysaccharides (LPS), isoproterenol, cocaine, and ionizing radiation.
Brimonidine Tartrate 是一种高度选择性 α-adrenergic receptor 拮抗剂,其对α2A adrenoreceptor的 EC50 为 0.45 nM ,并用于治疗开角型青光眼或高眼压症。
More(S)-Timolol Maleate是非选择性β-肾上腺素受体拮抗剂,对β1和β2受体亚型的Ki分别为1.97和2.0 nM。
MoreLY-2584702是p70S6K信号转导口服性抑制剂,能抑制和阻止核糖体S6亚基的磷酸化。
MoreYohimbine hydrochloride 是α-2肾上腺素能受体抑制剂,阻断突触前或突触后的α-2肾上腺素能受体,引起去甲肾上腺素和多巴胺的释放。
MorePhenoxybenzamine hydrochloride是非特异性的不可逆的α肾上腺素受体长效拮抗剂。
MoreBrimonidine Tartrate 是一种高度选择性 α-adrenergic receptor 拮抗剂,其对α2A adrenoreceptor的 EC50 为 0.45 nM ,并用于治疗开角型青光眼或高眼压症。
More(S)-Timolol Maleate是非选择性β-肾上腺素受体拮抗剂,对β1和β2受体亚型的Ki分别为1.97和2.0 nM。
MoreLY-2584702是p70S6K信号转导口服性抑制剂,能抑制和阻止核糖体S6亚基的磷酸化。
MoreYohimbine hydrochloride 是α-2肾上腺素能受体抑制剂,阻断突触前或突触后的α-2肾上腺素能受体,引起去甲肾上腺素和多巴胺的释放。
MorePhenoxybenzamine hydrochloride是非特异性的不可逆的α肾上腺素受体长效拮抗剂。
More